The streamlined design makes regular administrations more manageable, especially for those with needle anxiety or limited manual dexterity
Others prefer evening injection so they sleep through the initial GI effects
Worrying about when hot flashes will happen can be stressful
When it comes to the efficacy of weight loss, both Mounjaro and Retatrutide have demonstrated impressive results, but there are some notable differences
For patients interested in participating in research , the following resources may be helpful: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) search for Parkinson's and GLP-1 trials Parkinson's UK (www.parkinsons.org.uk) information on current research and trial opportunities When to contact your GP or specialist : If you have Parkinson's disease and diabetes, and wish to discuss whether a GLP-1 receptor agonist is appropriate for your diabetes management If you experience new or worsening symptoms whilst taking any medication If you are interested in clinical trial participationyour neurologist can advise on suitable studies Seek urgent medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Signs of dehydration (extreme thirst, dark urine, dizziness) Allergic reaction (rash, swelling, difficulty breathing) Patients should never start, stop, or modify medications without medical supervision
Anticoagulants like heparin, warfarin, and newer direct oral anticoagulants (DOACs) present the most obvious interaction question
